Dimension is a venture capital firm specializing in early-stage investments at the intersection of technology and life sciences. Established in 2022, Dimension operates from offices in New York and San Francisco.
Dimension Capital I:
Launched in 2022 with $350 million, focusing on early-stage investments in drug discovery, life sciences, machine learning, artificial intelligence, advanced manufacturing, and software sectors.
Dimension Capital II:
Closed in October 2024, raising $500 million to continue investing in startups at the intersection of technology and biology. This fund exceeded its $400 million target, reflecting strong investor interest.
Team
Dimension was co-founded by:
Notable Investments
Dimension's portfolio includes companies such as:
United States
